AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 83 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $121,000 | +8.0% | 21,800 | +86.3% | 0.04% | +362.5% |
Q1 2018 | $112,000 | -52.9% | 11,700 | -3.3% | 0.01% | -80.5% |
Q3 2017 | $238,000 | +98.3% | 12,100 | +5.2% | 0.04% | +127.8% |
Q4 2016 | $120,000 | -23.1% | 11,500 | -33.1% | 0.02% | -58.1% |
Q3 2016 | $156,000 | -73.1% | 17,200 | -61.7% | 0.04% | -78.9% |
Q4 2015 | $580,000 | +111.7% | 44,906 | +58.1% | 0.20% | +164.9% |
Q3 2015 | $274,000 | – | 28,397 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |